Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis.
about
Homogeneous Biosensing Based on Magnetic Particle LabelsAttitudes about tuberculosis prevention in the elimination phase: a survey among physicians in GermanyThe dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection.Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection.The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent InfectionAntigen-Specific IP-10 Release Is a Sensitive Biomarker of Mycobacterium bovis Infection in Cattle.Understanding immune protection against tuberculosis using RNA expression profilingHigh IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active TuberculosisCytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected Controls.T7 Phage Display Library a Promising Strategy to Detect Tuberculosis Specific Biomarkers.Development and evaluation of a diagnostic cytokine-release assay for Mycobacterium suricattae infection in meerkats (Suricata suricatta).Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrumPerformance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in TanzaniaIdentification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response.The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition.Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.Function and Potentials of M. tuberculosis EpitopesGetting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis.Prevalence and risk factors of latent tuberculosis infection in Africa: a systematic review and meta-analysis protocol.Concordance between IFNγ gene +874 A/T polymorphism and interferon-γ expression in a TB-endemic indigenous setting.New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets?Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.Optimizing the management of children with latent tuberculosis infection.Alternative Quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana.CXCL9, a promising biomarker in the diagnosis of chronic Q fever.Superior Sensitivity of Ex Vivo IFN-γ Release Assays as Compared to Skin Testing in Immunocompromised Patients.IP-10 Kinetics in the First Week of Therapy are Strongly Associated with Bacteriological Confirmation of Tuberculosis Diagnosis in HIV-Infected Patients.Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice.Latent tuberculosis infection: An overview.First Steps in Biomarker Assessment for Reactivation Risk in Latent Tuberculosis Infection.Screening of a ScFv Antibody With High Affinity for Application in Human IFN-γ Immunoassay.Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infectionBoosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection
P2860
Q26747505-49A03E39-DD56-49EF-B2A8-65AAB0A3748CQ28397652-997D45E5-9FBA-49D7-924A-9E7C4D158F5AQ33751671-ABEA9A1E-F596-4B21-A9AF-51C2D3FA3D18Q34128381-3A1FA4C5-B58C-4840-89CC-A7A0DA324F5DQ35188912-08EBDBD4-68D7-4C12-816B-BEBCD7B82E98Q35192333-5FB603E7-FDEF-4060-A96E-C4FD2E4480EBQ35895230-AD0C68DC-8F9E-4C1A-A256-6F2AE31E547DQ35924945-487EFC64-1031-4650-97D4-083418F9FB78Q35976624-DBA37161-52D4-45DB-AF37-7A9716F08A45Q36014226-F0370192-DD4E-4F94-ADB2-BC108CBC86EBQ36092310-129D8A42-DEBF-48C8-A85F-90F4345A22B8Q36125478-2301D311-3758-42E7-8834-15035B0D5488Q36148431-7BC1AD75-4B53-4BBE-96EA-4894632ADA1BQ36199050-51CC0E24-42F5-4C88-86EE-666BCE32B83DQ36239765-56B4314E-2581-47F4-947A-F7B8A9682461Q36423474-E2B57241-EFFC-4044-A8F8-21DA46FFAA70Q36776006-52DF6DC9-C792-42AE-B9BA-E896D2B0F13FQ37628903-DC88C1A5-0314-4146-9E69-3DF3AF34CE72Q37679327-C1AB1BBB-28B7-4619-B412-1D13E0C940EDQ37741088-407E8ABE-E09B-41F5-86AE-E1F44AF6E7A3Q38203257-08963A1D-20DF-4EF1-B868-629E18839BA1Q38221214-341B0A11-088F-4221-BBB5-DB3C5F253974Q38673273-D138764C-6480-4888-BA0C-5BEF8172B027Q38753906-11203B9A-1BC8-4B1A-8DEB-7B47E732B6E5Q38829376-D6593F88-5139-41CF-AA88-5FBC3EF40834Q38854712-31DD0E82-08D0-47EA-B01C-81DE1607EB7AQ39079240-17AFAEFE-F7ED-4714-975A-1402CB3E42A6Q39194281-6E00DB03-2D91-4894-B408-F9D5F6DB872FQ40043965-117F1980-525F-48BE-ADC9-969B474428B2Q41201019-65840C30-A87D-489A-A088-40D65960F785Q47129902-2D639A5E-AB46-449A-AB17-276F1D73E00FQ47134742-0D3E6FD9-5535-42DE-BCA6-65108F958DFDQ54207984-645BC2AB-BA4E-455A-BFD4-4340AD50E7EAQ54775910-65C7EACF-65C0-4D34-8247-1709426F320DQ55081684-DB2F065C-5979-47A2-B7CF-630C57907042Q57148761-11A7A6C5-3FCE-4352-A56B-45ADC9D8A0B5Q58696258-3E9D2236-F606-419E-A595-FE3C1D69A46F
P2860
Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Beyond the IFN-γ horizon: biom ...... th Mycobacterium tuberculosis.
@en
type
label
Beyond the IFN-γ horizon: biom ...... th Mycobacterium tuberculosis.
@en
prefLabel
Beyond the IFN-γ horizon: biom ...... th Mycobacterium tuberculosis.
@en
P50
P1476
Beyond the IFN-γ horizon: biom ...... ith Mycobacterium tuberculosis
@en
P2093
Jan Heyckendorf
Morten Ruhwald
P304
P356
10.1183/09031936.00151413
P577
2013-12-05T00:00:00Z